ABU DHABI - Allen & Overy has advised NMC Health PLC, the leading integrated healthcare provider operating across the United Arab Emirates, on its acquisition of a 51% shareholding in Fakih IVF Group, for AED696m (USD189 m). Fakih IVF, which comprises of Fakih IVF LLC and Fakih IVF Fertility Center LLC, is the UAE market leader for in-vitro fertilisation (IVF) services, performing over 4,000 IVF cycles per annum and offering the only full service genetics laboratory in the Middle East.
The collaboration with Fakih IVF is expected to be highly synergistic allowing cross referral of patients and the transfer of best practices and technologies within NMC's Maternity & Fertility vertical, which currently includes Bright point Royal Women's Hospital, Clinica Eugin (the top global fertility care provider based in Europe) and Fakih IVF. Patients will have access to a comprehensive healthcare platform, including local IVF treatments of the highest international standards.
The Allen & Overy team was led by corporate partner Khalid Garousha with support from corporate associate Alee Hadaya.
Commenting on the acquisition, Khalid Garousha said: "We are delighted to have played a part in this deal to strengthen the healthcare service offering in the Middle East region, and to assist NMC towards achieving its goal of becoming a global leader in maternity and fertility services."
-Ends-
For further information, please contact Suzy Baxter, suzy.baxter@allenovery.com, +971 (0)4 426 7155.
1. Allen & Overy is an international legal practice with approximately 5000 people, including some 527 partners, working in 44 offices worldwide.
2. In this press release 'Allen & Overy' means Allen & Overy LLP and/or its affiliated undertakings.
3. The term 'partner' is used to refer to a member of Allen & Overy LLP or an employee or consultant with equivalent standing and qualifications or an individual with equivalent status in one of Allen & Overy LLP's affiliated undertakings.
© Press Release 2015
